British consumer healthcare group Haleon on Tuesday said it gained full control of its Chinese joint venture after acquiring ...

Haleon PLC closed 10.34% below its 52-week high of £4.18, which the company achieved on March 4th.

Settlement may compensate consumers who bought Robitussin cough medicine products that were falsely marketed as "non-drowsy." ...

Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors and the consumer healthcare firm at 385 pence per share, a bookrunner for ...

Consumer healthcare company Haleon Pakistan Limited on Thursday named Qawi Naseer as the next Chief Executive Officer (CEO) ...

Haleon Pakistan Limited (PSX: HALEON) has decided to appoint Qawi Naseer as Chief Executive Officer of the company. The current Chief Executive Officer ...

Haleon announced on Tuesday that it has agreed to acquire the remaining 12% stake in its Chinese over-the-counter joint venture, Tianjin TSKF Pharmaceutical, for CNY 1.623bn (around £200m), bringing ...

As a hybrid healthcare and consumer staple stock, Haleon offers plenty of stability amidst the current market volatility, with its Power Brands driving strong organic growth. Room for expanding ...

Moody's Ratings has upgraded the long-term issuer rating of Haleon plc and its guaranteed subsidiaries to A3 from Baa1. The rating agency also upgraded the rating on Haleon's backed senior unsecured ...

Haleon has gained full control of its Chinese joint venture after acquiring Tianjin Pharmaceutical Da Ren Tang's 12% stake.

Haleon PLC closed 11.52% short of its 52-week high of £4.18, which the company reached on March 4th.